Company Overview
Snapshot
Founded in May 2017 by Dr. Shulamit Richter Dayan, Dermafence operates with 1–10 employees. The company has secured $20,000 in total funding across three rounds from one investor. In March 2018, Dermafence received a grant from the Israel Innovation Authority.
Business overview
Dermafence is a Health Tech & Life Sciences company focused on developing proprietary technology for burn treatment. The company's core technology utilizes a GRAS formulation with a novel mechanism of action designed to prevent energy from penetrating deeper skin layers. Dermafence has developed a first-aid burn formulation that aims to restore and protect epidermal skin barrier function following exposure to insults that introduce energy to the skin, serving the medical technologies market.
Log in to access full profile ›Company Intelligence Q&A
- When was Dermafence founded?
- Dermafence was founded in May 2017 by Dr. Shulamit Richter Dayan.
- What is Dermafence's primary focus?
- Dermafence specializes in developing proprietary technology for the treatment of burns, utilizing a GRAS formulation to protect and restore the skin barrier.
- How much capital has Dermafence raised to date?
- Dermafence has raised a total of $20,000 across three funding rounds.
- What is the employee count for Dermafence?
- Dermafence currently has 1–10 employees.